ARMISTICE CAPITAL, LLC

Q3 2021 13F-HR Detailed Holdings

Location
New York, NY
Holdings as of
9/30/2021
Date filed
11/15/2021
Form type
13F-HR
Num holdings
139
Total value ($000)
$5,903,915
Net value change ($000)
+317,349 (5.7%)
New positions
43
Sold out positions
26
Turnover %
33.9%
Sector allocation + QoQ delta (equities-only)

Holdings broken out by other managers reported in the original SEC filing. View aggregated holdings

Prev filing: 8/16/2021 Next filing: 2/14/2022 SEC filing
You are on the SEC detailed breakdown page. Rows are shown as reported in the filing (including other manager, discretion, and voting authority fields), and are not merged like the standard holdings view. Switch to aggregated holdings.

Snapshot: Change Analysis

Compared to Q2 2021
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
AVTX 98,100 NEW
INCY 82,045 101.2%
FIVE 67,412 NEW
PCRX 52,416 NEW
BAX 46,649 NEW
JAZZ 42,188 NEW
LOW 39,846 NEW
POST 34,370 NEW
BBY 34,269 NEW
NFLX 34,179 NEW
Top Reduces (Value $000, Stocks/ETFs)
AVTX -127,857 -100.0%
CPB -59,815 -100.0%
LULU -56,933 -100.0%
AMZN -48,226 -56.1%
TH -46,348 -100.0%
WOO -31,135 -100.0%
CLX -29,479 -58.9%
PFE -29,347 -73.2%
WSM -27,619 -67.3%
BIORA THERAPEUTICS, INC. -27,122 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 1,857,842 (31.5% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type Discretion Other Manager Sole Shared None